MedCap is a renowned brand that specializes in acquiring and developing small to medium-sized, well-managed Life Science companies. With a focus on capital, expertise, experience, and networks within the respective companies' fields of operation, MedCap aims to create value in the field of Life Science. The brand's ownership is predominantly long-term and actively exercised, while maintaining a professional approach and respect for company traditions.

MedCap operates within two areas: medical technology and specialty pharmaceuticals. Since 2001, they have successfully executed acquisitions, refinancing, and sales. Their portfolio includes diverse companies such as Abilia, specializing in cognitive aids and alarms; Cardiolex, offering EKG solutions and software; and Unimedic, focusing on specialty pharmaceuticals and CDMO services.

Other companies such as Inpac, Multi-Ply, and Trident are also part of MedCap's growing portfolio, offering products ranging from contract manufacturing to accessibility aids. As a brand, MedCap is committed to sustainable growth and contributing to the achievement of the United Nations' global goals. Their dedication to the Life Science sector makes them a valuable player in the industry.

Contact MedCap today to learn more about their investment strategy and become a part of their thriving community